细胞株Cell Lines 75及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV75
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID NC-NC
AC CVCL_1874
DR CLO; CLO_0008130
DR EFO; EFO_0007115
DR CLDB; cl3650
DR BioSample; SAMN03473410
DR DSMZ; ACC-120
DR ENCODE; ENCBS795ODE
CC Doubling time: ~50-60 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NCB-20
AC CVCL_H606
SY NCB20
DR TKG; TKG 0727
RX PubMed=1150088;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-386.html
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID NCC-19
AC CVCL_8897
SY SNU-NCC-19
DR Cosmic; 1661028
DR KCLB; 50019
RX PubMed=22361929;
CC Doubling time: 59 hours (PubMed=22361929).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,13
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,12
ST FGA: 20,23
ST TH01: 6,9
ST TPOX: 9
ST vWA: 18
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-20
AC CVCL_8898
SY SNU-NCC-20
DR Cosmic; 1661029
DR KCLB; 50020
RX PubMed=22361929;
CC Doubling time: 135 hours (PubMed=22361929).
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 8,11
ST FGA: 23
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-24
AC CVCL_8899
SY SNU-NCC-24
DR Cosmic; 1661030
DR KCLB; 50024
RX PubMed=22361929;
CC Doubling time: 47 hours (PubMed=22361929).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8
ST D3S1358: 15,18
ST D5S818: 10,11
ST D7S820: 10,12
ST FGA: 23
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-59
AC CVCL_8900
SY SNU-NCC-59
DR Cosmic; 1661031
DR KCLB; 50059
RX PubMed=22361929;
CC Doubling time: 50 hours (PubMed=22361929).
CC Derived from metastatic site: Ascites.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,14
ST D3S1358: 14,15
ST D5S818: 12,14
ST D7S820: 11,13
ST FGA: 21
ST TH01: 9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-BD1
AC CVCL_7883
RX CelloPub=CLPUB00275;
RX PubMed=20088962;
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-BD2
AC CVCL_7884
RX CelloPub=CLPUB00275;
RX PubMed=20088962;
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-c-CX-1
AC CVCL_IM30
SY CX-1
RX PubMed=1721614;
CC Characteristics: Contains 50-100 copies of the HPV18 genome.
CC Characteristics: There are about 16 copies of MYC in this cell line.
CC Doubling time: 21.8 hours (PubMed=1721614).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-CC1
AC CVCL_7885
RX CelloPub=CLPUB00275;
RX PubMed=20088962;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-CC3-1
AC CVCL_7886
RX CelloPub=CLPUB00275;
RX PubMed=20088962;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7887 ! NCC-CC3-2
SX Female
CA Cancer cell line
//
ID NCC-CC3-2
AC CVCL_7887
RX CelloPub=CLPUB00275;
RX PubMed=20088962;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7886 ! NCC-CC3-1
SX Female
CA Cancer cell line
//
ID NCC-CC4-1
AC CVCL_7888
RX CelloPub=CLPUB00275;
RX PubMed=20088962;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-CoC-K115B
AC CVCL_8321
DR JCRB; JCRB1339
DR JCRB; NIHS0510
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: JCRB; NIHS0510; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 7,12
ST D13S317: 11,12
ST D16S539: 9,10
ST D5S818: 10,13
ST D7S820: 8
ST TH01: 9
ST TPOX: 9
ST vWA: 18
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8320 ! NCC-CoC-K115L
OI CVCL_8319 ! NCC-CoC-K115P
SX Male
CA Transformed cell line
//
ID NCC-CoC-K115L
AC CVCL_8320
DR JCRB; JCRB1333
DR JCRB; NIHS0509
CC Discontinued: JCRB; NIHS0509; true.
CC Derived from metastatic site: Peripheral lymph node.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,10
ST D5S818: 10
ST D7S820: 8
ST TH01: 9
ST TPOX: 9
ST vWA: 18
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8321 ! NCC-CoC-K115B
OI CVCL_8319 ! NCC-CoC-K115P
SX Male
CA Cancer cell line
//
ID NCC-CoC-K115P
AC CVCL_8319
DR JCRB; JCRB1320
DR JCRB; NIHS0508
CC Discontinued: JCRB; NIHS0508; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,10
ST D5S818: 10
ST D7S820: 8
ST TH01: 9
ST TPOX: 9
ST vWA: 18
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8321 ! NCC-CoC-K115B
OI CVCL_8320 ! NCC-CoC-K115L
SX Male
CA Cancer cell line
//
ID NCC-EC-1
AC CVCL_8316
RX PubMed=2842544;
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-EC-2
AC CVCL_8317
RX PubMed=2842544;
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-EC-3
AC CVCL_8318
RX PubMed=2842544;
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-IT
AC CVCL_1451
SY NCCIT
DR BTO; BTO:0004180
DR CLO; CLO_0007955
DR ATCC; CRL-2073
DR BCRC; 60314
DR BCRJ; 0369
DR BioSample; SAMN03471433
DR ChEMBL-Cells; CHEMBL3308379
DR ChEMBL-Targets; CHEMBL1075511
DR Cosmic; 687051
DR Cosmic; 908441
DR Cosmic; 1090412
DR Cosmic; 2077186
DR Cosmic; 2163758
DR Cosmic-CLP; 908441
DR GEO; GSM1670159
DR NCBI_Iran; C624
DR Wikidata; Q17578676
RX PubMed=2842544;
RX PubMed=27397505;
WW https://de.wikipedia.org/wiki/NCC-IT_(Zelllinie)
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Misspelling: 'NCC15' in PubMed=24812411 and Cosmic 2163758.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 10,13
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-IT-A3
AC CVCL_3045
SY NCCIT-A3
DR JCRB; JCRB1005
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 10,13
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1451 ! NCC-IT
SX Male
CA Cancer cell line
//
ID NCC-KT
AC CVCL_GS47
RX PubMed=15160996;
CC From: Hamanaka Y.; Yamaguchi University School of Medicine; Ube; Japan.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCC-OvC-K119
AC CVCL_3046
DR BioSample; SAMN03472397
DR JCRB; JCRB1308
DR JCRB; NIHS0507
DR RCB; RCB2223
CC Misspelling: 'NCC-OvC-K1119' in RCB RCB2223.
CC Discontinued: JCRB; NIHS0507; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 11
ST D5S818: 9
ST D7S820: 12,13
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-RbC-30
AC CVCL_U796
SY NCC-RbC-R30
RX PubMed=8263010;
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-RbC-39
AC CVCL_3047
DR CLO; CLO_0050128
DR BioSample; SAMN01821704
DR BioSample; SAMN03472394
DR JCRB; JCRB1305
DR JCRB; NIHS0511
DR RCB; RCB2205
RX CelloPub=CLPUB00087;
CC Discontinued: JCRB; NIHS0511; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,10
ST D16S539: 12
ST D5S818: 9,10
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-RbC-51
AC CVCL_3048
SY NCC-RBC-51; R51; NCC-RbC-R51
DR CLO; CLO_0050135
DR BioSample; SAMN01821705
DR BioSample; SAMN03472423
DR JCRB; JCRB1182
DR RCB; RCB2206
RX PubMed=8263010;
RX PubMed=12406979;
ST Source(s): JCRB; RCB
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 11,12
ST D16S539: 10,12
ST D5S818: 10
ST D7S820: 12
ST TH01: 9
ST TPOX: 9,11
ST vWA: 14
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-RbC-53
AC CVCL_8309
DR BioSample; SAMN03472433
DR JCRB; JCRB1200
DR JCRB; NIHS0496
RX PubMed=8263010;
CC Discontinued: JCRB; NIHS0496; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 8
ST vWA: 18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-RbC-54
AC CVCL_3049
DR CLO; CLO_0050130
DR BioSample; SAMN03472019
DR BioSample; SAMN03472424
DR JCRB; JCRB1183
DR JCRB; NIHS0497
DR RCB; RCB2208
RX PubMed=8263010;
CC Discontinued: JCRB; NIHS0497; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 9,14
ST D7S820: 9,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,18 (JCRB)
ST vWA: 16 (RCB)
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-RbC-56
AC CVCL_3050
SY NCC-RbC-R56
DR BioSample; SAMN03472438
DR JCRB; JCRB1212
DR JCRB; NIHS0498
RX PubMed=8263010;
CC Discontinued: JCRB; NIHS0498; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 10
ST D16S539: 9
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-RbC-57
AC CVCL_3051
DR BioSample; SAMN03472426
DR JCRB; JCRB1190
DR JCRB; NIHS0499
RX PubMed=8263010;
CC Discontinued: JCRB; NIHS0499; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 10,12
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8,10
ST vWA: 18,19
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-RbC-58
AC CVCL_U795
RX PubMed=8263010;
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-RbC-59
AC CVCL_4072
SY NCC-RbC-R59
DR CLO; CLO_0050134
DR BioSample; SAMN01821706
DR BioSample; SAMN03472425
DR JCRB; JCRB1186
DR JCRB; NIHS0500
DR RCB; RCB2212
RX PubMed=8263010;
CC Discontinued: JCRB; NIHS0500; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-RbC-60
AC CVCL_4073
DR CLO; CLO_0050131
DR BioSample; SAMN03472020
DR JCRB; JCRB1326
DR JCRB; NIHS0501
DR RCB; RCB2213
RX PubMed=8263010;
CC Discontinued: JCRB; NIHS0501; true.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 10,13
ST D7S820: 11
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-RbC-67
AC CVCL_3052
DR CLO; CLO_0050127
DR BioSample; SAMN01821707
DR BioSample; SAMN03472441
DR JCRB; JCRB1214
DR RCB; RCB2214
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 8,12
ST D7S820: 10
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-RbC-70
AC CVCL_8143
RX PubMed=8263010;
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-RbC-83
AC CVCL_4074
DR CLO; CLO_0050132
DR BioSample; SAMN01821708
DR BioSample; SAMN03472393
DR JCRB; JCRB1303
DR JCRB; NIHS0503
DR RCB; RCB2217
CC Discontinued: JCRB; NIHS0503; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9
ST D5S818: 11
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-RbC-92
AC CVCL_3053
DR CLO; CLO_0050133
DR BioSample; SAMN03472446
DR JCRB; JCRB1221
DR JCRB; NIHS0504
DR RCB; RCB2218
CC Discontinued: JCRB; NIHS0504; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,10
ST D16S539: 9,11
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 18,20
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC-RbC-T1
AC CVCL_3054
DR CLO; CLO_0050129
DR BioSample; SAMN03472021
DR JCRB; JCRB1223
DR RCB; RCB2219
RX PubMed=8263010;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 10,13
ST D7S820: 9,10
ST TH01: 7,8
ST TPOX: 8,10
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC-StC-K140
AC CVCL_3055
DR CLO; CLO_0050803
DR BioSample; SAMN03472022
DR BioSample; SAMN03472448
DR CCLE; NCCSTCK140_STOMACH
DR GEO; GSM888427
DR JCRB; JCRB1228
DR RCB; RCB2224
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 12
ST D5S818: 9
ST D7S820: 11,12 (JCRB)
ST D7S820: 12 (RCB)
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCC010
AC CVCL_X505
DR Cosmic-CLP; 1509073
DR GDSC; 1509073
DR GEO; GSM1670157
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 10,13
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCC021
AC CVCL_X506
DR Cosmic-CLP; 1509074
DR GDSC; 1509074
DR GEO; GSM1670158
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,9
ST D16S539: 9
ST D5S818: 9,13
ST D7S820: 9
ST TH01: 9
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCC16
AC CVCL_U219
DR BioSample; SAMN03151898
DR BioSample; SAMN03470809
DR JCRB; JCRB0142
DR JCRB; NIHS0204
RX PubMed=9310137;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PHK16-0b derivative (PubMed=20143388).
CC Caution: Replaced by NCC16-P11.
CC Discontinued: JCRB; JCRB0142; true.
CC Discontinued: JCRB; NIHS0204; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 9,11
ST D7S820: 9,11
ST TH01: 10
ST TPOX: 8
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3123 ! PHK16-0b
SX Male
CA Transformed cell line
//
ID NCC16-P11
AC CVCL_3044
DR BioSample; SAMN03472368
DR JCRB; JCRB0174.0
DR JCRB; NIHS0259.0
RX PubMed=9310137;
CC Caution: Original cell line NCC16 was contaminated and retired, it was replaced by NCC16-P11.
CC Discontinued: JCRB; NIHS0259.0; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NCE SVIA6
AC CVCL_8373
SY NCEsv-IA6.2
DR BioSample; SAMN03472507
DR JCRB; JCRB1092
DR JCRB; NIHS0263
RX PubMed=12747968;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: JCRB; NIHS0263; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 10,13
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NCE SVIIA3
AC CVCL_8374
DR JCRB; JCRB1091
DR JCRB; NIHS0264
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: JCRB; NIHS0264; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 9,12
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NCE-F161
AC CVCL_3754
DR CLO; CLO_0007956
DR ATCC; CRL-8727
RX Patent=US4933179;
OX NCBI_TaxID=9685; ! Felis catus
CA Transformed cell line
//
ID NCE-G 102
AC CVCL_N738
SY G-102; G102; NeuroChirurgie Eppendorf-Glioma 102
RX PubMed=3063073;
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCE-G 111
AC CVCL_N739
SY NCE-G111; G-111; G111; NeuroChirurgie Eppendorf-Glioma 111
DR EFO; EFO_0006395
DR BioSample; SAMN03472646
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 10,12
ST D18S51: 15
ST D21S11: 28
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 9
ST Penta E: 7,11
ST TH01: 6
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 112
AC CVCL_N740
SY NCE G-112; NCE G 112; NCE-G112; G-112; G112; NeuroChirurgie Eppendorf-Glioma 112
DR EFO; EFO_0006396
DR BioSample; SAMN03471511
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12
ST D21S11: 28
ST D3S1358: 14,17
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 9,12
ST Penta E: 7,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 118
AC CVCL_N741
SY NCE G-118; NCE-G118; G-118; G118; NeuroChirurgie Eppendorf-Glioma 118
DR EFO; EFO_0006397
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 120
AC CVCL_N742
SY NCE G 120; NCE-G120; G-120; G120; NeuroChirurgie Eppendorf-Glioma 120
DR EFO; EFO_0006398
DR BioSample; SAMN03471174
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,14
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 15
ST D21S11: 29,31
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 10,13
ST D8S1179: 14,15
ST FGA: 21,24
ST Penta D: 11,12
ST Penta E: 11,17
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 121
AC CVCL_N743
SY NCE-G121; G-121; G121; NeuroChirurgie Eppendorf-Glioma 121
DR EFO; EFO_0006399
DR BioSample; SAMN03471076
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Caution: Said to originate from a male patient according to PubMed=8289093 and PubMed=16696057, in contradiction with PubMed=8154317.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10
ST D16S539: 12
ST D18S51: 15,16
ST D21S11: 30,32.2
ST D3S1358: 14,15
ST D5S818: 12,13
ST D7S820: 10,12
ST D8S1179: 11,13
ST FGA: 20
ST Penta D: 9,12
ST Penta E: 11,17
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 122
AC CVCL_N744
SY NCE G 122; NCE-G122; G-122; G122; NeuroChirurgie Eppendorf-Glioma 122
DR EFO; EFO_0006400
DR BioSample; SAMN03471500
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12
ST D21S11: 28
ST D3S1358: 14,17
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 9,12
ST Penta E: 7,11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 123
AC CVCL_N745
SY NCE G 123; NCE-G123; G-123; G123; NeuroChirurgie Eppendorf-Glioma 123
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=16696057;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 123T2
AC CVCL_BW89
SY G123T2
RX PubMed=19519771;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N745 ! NCE-G 123
SX Male
CA Cancer cell line
//
ID NCE-G 124
AC CVCL_N746
SY NCE G 124; NCE-G124; G-124; G124; NeuroChirurgie Eppendorf-Glioma 124
DR EFO; EFO_0006401
DR BioSample; SAMN03471185
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 12,15
ST D21S11: 28,32.2
ST D3S1358: 17,18
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 13,15
ST FGA: 20,22
ST Penta D: 9,12
ST Penta E: 11,16
ST TH01: 6
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 130
AC CVCL_N747
SY NCE G 130; NCE-G130; G-130; G130; NeuroChirurgie Eppendorf-Glioma 130
DR EFO; EFO_0006402
DR BioSample; SAMN03472657
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 12,18
ST D21S11: 27,29
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 7,10
ST D8S1179: 13
ST FGA: 22,23
ST Penta D: 12
ST Penta E: 5,7
ST TH01: 7
ST TPOX: 8
ST vWA: 15
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 140
AC CVCL_N748
SY NCE-G140; G-140; G140; NeuroChirurgie Eppendorf-Glioma 140
DR EFO; EFO_0006403
DR BioSample; SAMN03472635
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11
ST D18S51: 16
ST D21S11: 28,29
ST D3S1358: 15,17
ST D5S818: 10,11
ST D7S820: 8,9
ST D8S1179: 11,15
ST FGA: 23,25
ST Penta D: 9,11
ST Penta E: 12,19
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 141
AC CVCL_N749
SY NCE-G141; G-141; G141; NeuroChirurgie Eppendorf-Glioma 141
DR EFO; EFO_0006404
DR BioSample; SAMN03472668
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 12
ST D21S11: 30.2,31.2
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 14,16
ST FGA: 19,20
ST Penta D: 12,15
ST Penta E: 12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 142
AC CVCL_N750
SY NCE-G142; G-142; G142; NeuroChirurgie Eppendorf-Glioma 142
DR EFO; EFO_0006405
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 151
AC CVCL_N751
SY G-151; G151; NeuroChirurgie Eppendorf-Glioma 151
RX PubMed=8154317;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 167
AC CVCL_N752
SY G-167; G167; NeuroChirurgie Eppendorf-Glioma 167
RX PubMed=16696057;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 168
AC CVCL_N753
SY NCE G 168; NCE G168; NCE-G168; G-168; G168; NeuroChirurgie Eppendorf-Glioma 168
RX PubMed=15816541;
RX PubMed=16696057;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 169
AC CVCL_N754
SY G-169; G169; NeuroChirurgie Eppendorf-Glioma 169
RX PubMed=16696057;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 195
AC CVCL_N755
SY NCE G195; G-195; G195; NeuroChirurgie Eppendorf-Glioma 195
RX PubMed=16696057;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 22
AC CVCL_N723
SY NCE G-22; NCE G 22; NCE-G22; G-22; G22; NeuroChirurgie Eppendorf-Glioma 22
DR EFO; EFO_0006406
DR BioSample; SAMN03472679
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 8
ST D16S539: 10,11,12,13
ST D18S51: 15,20
ST D21S11: 31.2,34.2
ST D3S1358: 15,19
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 12,13
ST FGA: 18,19,23
ST Penta D: 13
ST Penta E: 7,13
ST TH01: 6,7
ST TPOX: 8,9,11
ST vWA: 18,20,21
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 28
AC CVCL_N724
SY NCE G-28; NCE-G28; G-28; G28; NeuroChirurgie Eppendorf-Glioma 28
RX PubMed=3063073;
RX PubMed=3275500;
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
DI NCIt; C3796; Gliosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE G-28T
AC CVCL_0V15
SY NCE-G28T; G28T
DR EFO; EFO_0006407
DR BioSample; SAMN03471523
RX PubMed=3275500;
RX PubMed=8289093;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12
ST D18S51: 18
ST D21S11: 29
ST D3S1358: 14
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 10
ST FGA: 22
ST Penta D: 12
ST Penta E: 11
ST TH01: 6,8
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C3796; Gliosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N724 ! NCE-G 28
SX Male
CA Cancer cell line
//
ID NCE-G 30
AC CVCL_N725
SY G-30; G30; NeuroChirurgie Eppendorf-Glioma 30
RX PubMed=3063073;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCE-G 350
AC CVCL_N756
SY NCE-G350; G-350; G350; NeuroChirurgie Eppendorf-Glioma 350
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCE-G 38
AC CVCL_N726
SY G-38; G38; NeuroChirurgie Eppendorf-Glioma 38
RX PubMed=3063073;
RX PubMed=8154317;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 44
AC CVCL_N727
SY NCE G 44, NCE-G44; G-44; G44; NeuroChirurgie Eppendorf-Glioma 44
DR EFO; EFO_0006408
DR BioSample; SAMN03471534
RX PubMed=3063073;
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 12,14
ST D21S11: 27,29
ST D3S1358: 14,16
ST D5S818: 7,9
ST D7S820: 8,9
ST D8S1179: 12,14
ST FGA: 21,24
ST Penta D: 9,11
ST Penta E: 14,15
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 55
AC CVCL_N728
SY NCE G 55; NCE-G55; G-55; G55; NeuroChirurgie Eppendorf-Glioma 55
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 55T2
AC CVCL_BW88
SY NCE-G55T2; G55T2; NCEG55T2
DR BTO; BTO:0005458
RX PubMed=19519771;
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N728 ! NCE-G 55
SX Male
CA Cancer cell line
//
ID NCE-G 59
AC CVCL_N729
SY NCE-G59; G-59; G59; NeuroChirurgie Eppendorf-Glioma 59
DR EFO; EFO_0006409
DR BioSample; SAMN03471229
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 10,13
ST D18S51: 14,16
ST D21S11: 29,30.2
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 12
ST FGA: 21,24
ST Penta D: 10
ST Penta E: 13
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 60
AC CVCL_N730
SY G-60; G60; NeuroChirurgie Eppendorf-Glioma 60
RX PubMed=16696057;
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 61
AC CVCL_N731
SY NCE-G61; G-61; G61; NeuroChirurgie Eppendorf-Glioma 61
DR EFO; EFO_0006410
DR BioSample; SAMN03471240
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,14
ST D18S51: 18
ST D21S11: 30,32.2
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 9
ST D8S1179: 14
ST FGA: 20
ST Penta D: 9,11
ST Penta E: 7
ST TH01: 7
ST TPOX: 11
ST vWA: 17
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 62
AC CVCL_N732
SY NCE G 62; NCE-G62; G-62; G62; NeuroChirurgie Eppendorf-Glioma 62
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=16696057;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 63
AC CVCL_N733
SY NCE G-63; NCE G 63; NCE-G63; G-63; G63; NeuroChirurgie Eppendorf-Glioma 63
RX PubMed=3063073;
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=16696057;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCE-G 80
AC CVCL_N734
SY G-80; G80; NeuroChirurgie Eppendorf-Glioma 80
RX PubMed=3063073;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCE-G 84
AC CVCL_N735
SY NCE G 84; NCE-G84; G-84; G84; NeuroChirurgie Eppendorf-Glioma 84
DR EFO; EFO_0006411
DR BioSample; SAMN03471545
RX PubMed=8289093;
RX PubMed=15816541;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 11
ST D18S51: 19
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 12
ST D8S1179: 13,14
ST FGA: 21
ST Penta D: 12,13
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 96
AC CVCL_N736
SY NCE-G96; G-96; G96; NeuroChirurgie Eppendorf-Glioma 96
DR EFO; EFO_0006412
DR BioSample; SAMN03471163
RX PubMed=8154317;
RX PubMed=8289093;
RX PubMed=16696057;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 12,14
ST D21S11: 27,29
ST D3S1358: 14,16
ST D5S818: 7,9
ST D7S820: 8
ST D8S1179: 12,14
ST FGA: 21,24
ST Penta D: 9,11
ST Penta E: 14,15
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCE-G 98
AC CVCL_N737
SY G-98; G98; NeuroChirurgie Eppendorf-Glioma 98
RX PubMed=3063073;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCE16
AC CVCL_3057
DR BioSample; SAMN03470807
DR JCRB; JCRB0140
DR JCRB; NIHS0205
RX PubMed=9310137;
RX PubMed=12747968;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Discontinued: JCRB; NIHS0205; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,13
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NCE16-IIA
AC CVCL_3056
SY NCE 16IIA
DR BioSample; SAMN03472506
DR JCRB; JCRB1090
DR JCRB; NIHS0265
RX PubMed=12747968;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Discontinued: JCRB; NIHS0265; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 9,12
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3057 ! NCE16
SX Female
CA Transformed cell line
//
ID NCE16-IIB
AC CVCL_8304
SY NCE 16IIB
DR JCRB; JCRB1089
DR JCRB; NIHS0266
RX PubMed=12747968;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Discontinued: JCRB; JCRB1089; probable.
CC Discontinued: JCRB; NIHS0266; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 9,12
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3057 ! NCE16
SX Female
CA Transformed cell line
//
ID NCEB-1
AC CVCL_1875
SY Nceb-1; NCEB1; NCEB
DR ATCC; CRL-3005
DR BioSample; SAMN03471708
DR Cosmic; 1070711
DR Cosmic; 2296994
DR DSMZ; ACC-721
DR GEO; GSM95564
DR GEO; GSM95569
DR GEO; GSM104461
DR GEO; GSM115803
RX PubMed=2848599;
RX PubMed=7849311;
RX PubMed=16183118;
RX PubMed=16448697;
RX PubMed=16960149;
RX PubMed=25315077;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 19 hours (PubMed=25315077); ~50-70 hours (DSMZ).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: Seems to contain some murine chromosomes (PubMed=16448697).
ST Source(s): ATCC; DSMZ
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 9,11
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCF
AC CVCL_HA35
SY Neonatal Connective Fibroblast
DR BCRJ; 0183
CC Discontinued: BCRJ; 0183; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID NCF3
AC CVCL_IN83
RX PubMed=2470608;
RX PubMed=15463957;
CC Transformant: Ad12-SV40.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NCF3A
AC CVCL_IN84
RX PubMed=2470608;
CC Transformant: Ad12-SV40.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IN83 ! NCF3
SX Male
CA Transformed cell line
//
ID NCH125
AC CVCL_S818
SY NCH-125
RX PubMed=16331629;
CC Characteristics: Low-passage-number culture.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH149
AC CVCL_S819
SY NCH-149
RX PubMed=16331629;
CC Characteristics: Low-passage-number culture.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH37
AC CVCL_S820
SY NCH-37
DR ChEMBL-Cells; CHEMBL3307426
DR ChEMBL-Targets; CHEMBL614770
RX PubMed=16331629;
CC Characteristics: Low-passage-number culture.
DI NCIt; C3796; Gliosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH421k
AC CVCL_X910
SY NCH421K
DR CLS; 300118/p803_NCH421K
RX PubMed=20442299;
RX PubMed=24294177;
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 10,11
ST D18S51: 13
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 11,13
ST D7S820: 10,12
ST D8S1179: 12,15
ST FGA: 21,25
ST Penta D: 9,13
ST Penta E: 7,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH440
AC CVCL_X911
RX PubMed=20442299;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCH441
AC CVCL_X912
RX PubMed=20442299;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH465
AC CVCL_X944
RX PubMed=20442299;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCH57
AC CVCL_S821
SY NCH-57
CC Characteristics: Low-passage-number culture.
DI NCIt; C3796; Gliosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCH612
AC CVCL_X913
DR CLS; 300121/p884_NCH612
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10
ST D16S539: 11,13
ST D18S51: 13
ST D21S11: 28,31
ST D3S1358: 14,18
ST D5S818: 11,13
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 21
ST Penta D: 9,12
ST Penta E: 11,14
ST TH01: 6,7
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C4326; Anaplastic oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH644
AC CVCL_X914
DR CLS; 300124/p3514_NCH644
RX PubMed=24294177;
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,13
ST D16S539: 12,13
ST D5S818: 9,10
ST D7S820: 12,13
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH690
AC CVCL_X915
DR CLS; 300120/p3510_NCH690
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,13
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 8,9
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH82
AC CVCL_S822
SY NCH-82
DR ChEMBL-Cells; CHEMBL3307323
DR ChEMBL-Targets; CHEMBL614191
RX PubMed=16331629;
CC Characteristics: Low-passage-number culture.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCH89
AC CVCL_S823
SY NCH-89
DR ChEMBL-Cells; CHEMBL3307480
DR ChEMBL-Targets; CHEMBL614192
RX PubMed=16331629;
CC Characteristics: Low-passage-number culture.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-ADR-RES
AC CVCL_1452
AS CVCL_0414; CVCL_3942
SY NCI/ADR-RES; NCIADR.RES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR
DR BTO; BTO:0004181
DR MCCL; MCC:0000310
DR BioSample; SAMN03151880
DR BioSample; SAMN03151881
DR ChEMBL-Cells; CHEMBL3307592
DR ChEMBL-Cells; CHEMBL3308057
DR ChEMBL-Targets; CHEMBL613829
DR ChEMBL-Targets; CHEMBL614324
DR Cosmic; 687498
DR Cosmic; 897420
DR Cosmic; 905987
DR Cosmic; 974233
DR Cosmic; 1044218
DR Cosmic; 1092617
DR Cosmic; 1312358
DR Cosmic; 1998459
DR GEO; GSM50197
DR GEO; GSM50260
DR GEO; GSM750832
DR GEO; GSM799367
DR GEO; GSM799430
DR GEO; GSM847073
DR GEO; GSM844614
DR GEO; GSM844615
DR GEO; GSM1153433
DR GEO; GSM1181271
DR GEO; GSM1181300
DR SKY/M-FISH/CGH; 2897
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=2041050;
RX PubMed=9625176;
RX PubMed=16504380;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=20143388;
RX PubMed=21116879;
RX PubMed=27807467;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://dtp.cancer.gov/discovery_development/nci-60/nci-adrres.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=28
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380, PubMed=20143388).
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 34 hours (DTP).
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=19372543
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 13
ST D18S51: 14
ST D19S433: 14,16
ST D21S11: 28
ST D2S1338: 19,23
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 10
ST FGA: 20
ST TH01: 7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1629 ! OVCAR-8
SX Female
CA Cancer cell line
//
ID NCI-BL1184
AC CVCL_2635
SY BL1184
DR CLO; CLO_0007957
DR ATCC; CRL-5949
DR BioSample; SAMN03472611
DR BioSample; SAMN03472988
RX PubMed=8806092;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 16,20
ST D21S11: 28,32.2
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 10,11
ST FGA: 22,24
ST Penta D: 10,12
ST Penta E: 5,7
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 16 (ATCC)
ST vWA: 16,17 (PubMed=25877200)
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1458 ! NCI-H1184
SX Male
CA Transformed cell line
//
ID NCI-BL128
AC CVCL_2636
SY BL128
DR CLO; CLO_0007958
DR ATCC; CRL-5947
DR BioSample; SAMN03472609
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 13
ST D5S818: 9,12
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1460 ! NCI-H128
SX Male
CA Transformed cell line
//
ID NCI-BL1339
AC CVCL_2637
SY BL1339
DR CLO; CLO_0007959
DR ATCC; CRL-5950
DR BioSample; SAMN03472613
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A472 ! NCI-H1339
SX Female
CA Transformed cell line
//
ID NCI-BL1395
AC CVCL_2638
SY BL1395
DR CLO; CLO_0007960
DR ATCC; CRL-5957
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=8806092;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; DOI=10.4172/2157-7145.S2-005; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,14
ST D16S539: 11,13
ST D18S51: 12,14
ST D19S433: 13,16
ST D21S11: 28,29
ST D2S1338: 17,24
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 12,14
ST FGA: 18,23
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1467 ! NCI-H1395
SX Female
CA Transformed cell line
//
ID NCI-BL1437
AC CVCL_2639
SY BL1437
DR CLO; CLO_0007961
DR ATCC; CRL-5958
DR BioSample; SAMN03472619
RX PubMed=8806092;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 15,19
ST D21S11: 29,30
ST D5S818: 11,14
ST D7S820: 8,11
ST D8S1179: 11,13
ST FGA: 22,24
ST TH01: 6,8
ST TPOX: 9,10
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1472 ! NCI-H1437
SX Male
CA Transformed cell line
//
ID NCI-BL1450
AC CVCL_2640
SY BL1450
DR CLO; CLO_0007962
DR ATCC; CRL-5951
DR BioSample; SAMN03472614
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 11,12
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A466 ! NCI-H1450
OI CVCL_A495 ! NCI-H1451
SX Male
CA Transformed cell line
//
ID NCI-BL1474
AC CVCL_E096
SY BL1474
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NCI-BL1514
AC CVCL_2641
SY BL1514
DR CLO; CLO_0007963
DR ATCC; CRL-5952
DR BioSample; SAMN03472615
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,9
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 9,11
ST TH01: 8
ST TPOX: 11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4363 ! NCI-H1514
SX Male
CA Transformed cell line
//
ID NCI-BL1607
AC CVCL_2642
SY BL1607; NCI-BL9; BL9
DR CLO; CLO_0007964
DR ATCC; CRL-5953
DR BioSample; SAMN03472984
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,12
ST D16S539: 11,13
ST D18S51: 14,18
ST D21S11: 28,29
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 11,12
ST FGA: 18,25
ST Penta D: 10,12
ST Penta E: 11,16
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A467 ! NCI-H1607
SX Male
CA Transformed cell line
//
ID NCI-BL1648
AC CVCL_E097
SY BL1648
DR ATCC; CRL-5954
DR BioSample; SAMN03472616
DR Cosmic; 1887850
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-5954; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 8,11
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1482 ! NCI-H1648
SX Male
CA Transformed cell line
//
ID NCI-BL1672
AC CVCL_2643
SY BL1672
DR CLO; CLO_0007965
DR ATCC; CRL-5959
DR BioSample; SAMN03472987
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 9,11
ST D18S51: 13,14
ST D21S11: 29,32.2
ST D3S1358: 16,18
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 11,14
ST FGA: 21
ST Penta D: 8,12
ST Penta E: 8,9
ST TH01: 6,10
ST TPOX: 11,12
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1486 ! NCI-H1672
SX Male
CA Transformed cell line
//
ID NCI-BL1688
AC CVCL_E098
SY BL1688
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1487 ! NCI-H1688
SX Male
CA Transformed cell line
//
ID NCI-BL1770
AC CVCL_2644
SY BL1770
DR CLO; CLO_0007966
DR ATCC; CRL-5960
DR BioSample; SAMN03472620
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,13
ST D16S539: 12,13
ST D18S51: 14,16
ST D21S11: 30,32.2
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 20
ST TH01: 9
ST TPOX: 11
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1493 ! NCI-H1770
SX Male
CA Transformed cell line
//
ID NCI-BL1819
AC CVCL_E099
SY BL1819
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 15,17
ST D21S11: 29
ST D8S1179: 12,15
ST FGA: 20,22
ST TH01: 9,9.3
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1497 ! NCI-H1819
SX Female
CA Transformed cell line
//
ID NCI-BL1824
AC CVCL_E100
SY BL1824
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A512 ! NCI-H1824
SX Male
CA Transformed cell line
//
ID NCI-BL1963
AC CVCL_E101
SY BL1963
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1510 ! NCI-H1963
SX Male
CA Transformed cell line
//
ID NCI-BL1993
AC CVCL_E102
SY BL1993
RX PubMed=8806092;
RX PubMed=24297535;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Genome sequenced.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1512 ! NCI-H1993
OI CVCL_1521 ! NCI-H2073
SX Female
CA Transformed cell line
//
ID NCI-BL2009
AC CVCL_2645
SY BL2009
DR CLO; CLO_0007967
DR ATCC; CRL-5961
DR BioSample; SAMN03473257
DR CCRID; 3111C0001CCC000382
RX PubMed=8806092;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 14,18
ST D21S11: 29
ST D3S1358: 16,18
ST D5S818: 13
ST D7S820: 9,11
ST D8S1179: 10,15
ST FGA: 22,26
ST Penta D: 12,13
ST Penta E: 11,18
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1514 ! NCI-H2009
SX Female
CA Transformed cell line
//
ID NCI-BL2028
AC CVCL_2646
SY BL2028
DR CLO; CLO_0007968
DR ATCC; CRL-5962
DR BioSample; SAMN03472989
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 12,18
ST D21S11: 30
ST D3S1358: 14,18
ST D5S818: 10,11
ST D7S820: 8,9
ST D8S1179: 10,12
ST FGA: 21,22
ST Penta D: 9,11
ST Penta E: 11,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A522 ! NCI-H2028
SX Male
CA Transformed cell line
//
ID NCI-BL2052
AC CVCL_2647
SY BL2052
DR CLO; CLO_0007969
DR ATCC; CRL-5963
DR BioSample; SAMN03472621
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1518 ! NCI-H2052
SX Male
CA Transformed cell line
//
ID NCI-BL2077
AC CVCL_E103
SY BL2077
DR ATCC; CRL-5964
DR BioSample; SAMN03472622
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-5964; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5157 ! NCI-H2077
SX Male
CA Transformed cell line
//
ID NCI-BL2087
AC CVCL_2648
SY BL2087
DR CLO; CLO_0007970
DR ATCC; CRL-5965
DR BioSample; SAMN03472625
DR BioSample; SAMN03473258
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=11416159; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,11
ST D18S51: 14,16
ST D21S11: 30,32.2
ST D3S1358: 15,17
ST D5S818: 11,12,13 (ATCC)
ST D5S818: 11,12 (PubMed=25877200)
ST D7S820: 8,10
ST D8S1179: 10,12
ST FGA: 20,26
ST Penta D: 11,12
ST Penta E: 7,11
ST TH01: 7,9
ST TPOX: 11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1524 ! NCI-H2087
SX Male
CA Transformed cell line
//
ID NCI-BL209
AC CVCL_2649
SY BL209
DR CLO; CLO_0007971
DR ATCC; CRL-5948
DR BioSample; SAMN03472610
RX PubMed=8806092;
RX PubMed=14762065;
RX PubMed=20016488;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Genome sequenced.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 9
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1525 ! NCI-H209
SX Male
CA Transformed cell line
//
ID NCI-BL2107
AC CVCL_2650
SY BL2107
DR CLO; CLO_0007972
DR ATCC; CRL-5966
DR BioSample; SAMN03472985
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 8,11
ST D13S317: 12,13
ST D16S539: 10,13
ST D18S51: 15,17
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 13,14
ST D7S820: 8
ST D8S1179: 11,14
ST FGA: 19,22
ST Penta D: 11
ST Penta E: 8,13
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1527 ! NCI-H2107
OI CVCL_1528 ! NCI-H2108
SX Male
CA Transformed cell line
//
ID NCI-BL2122
AC CVCL_2651
SY BL2122
DR CLO; CLO_0007973
DR ATCC; CRL-5967
DR BioSample; SAMN03472986
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,10
ST D16S539: 9,12
ST D18S51: 15,19
ST D21S11: 31.2,33.2
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 19,26
ST Penta D: 10,12
ST Penta E: 11,14
ST TH01: 7,9.3
ST TPOX: 9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1531 ! NCI-H2122
SX Female
CA Transformed cell line
//
ID NCI-BL2126
AC CVCL_2652
SY BL2126
DR CLO; CLO_0007974
DR ATCC; CCL-256.1
DR BioSample; SAMN03471388
RX PubMed=8806092;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 11,14
ST D13S317: 12,14
ST D16S539: 12,13
ST D18S51: 14,16
ST D21S11: 29,30
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 12
ST FGA: 21,26
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1532 ! NCI-H2126
SX Male
CA Transformed cell line
//
ID NCI-BL2141
AC CVCL_2653
SY BL2141
DR CLO; CLO_0007975
DR ATCC; CRL-5955
DR BioSample; SAMN03472617
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,14
ST D16S539: 8,12
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1519 ! NCI-H2059
OI CVCL_1534 ! NCI-H2141
SX Male
CA Transformed cell line
//
ID NCI-BL2171
AC CVCL_2654
SY BL2171
DR CLO; CLO_0007976
DR ATCC; CRL-5969
DR BioSample; SAMN03472626
RX PubMed=8806092;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 12,13
ST D7S820: 11,13
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1536 ! NCI-H2171
SX Male
CA Transformed cell line
//
ID NCI-BL2195
AC CVCL_2655
SY BL2195
DR CLO; CLO_0007977
DR ATCC; CRL-5956
DR BioSample; SAMN03472618
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 10,14
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1538 ! NCI-H2195
OI CVCL_1539 ! NCI-H2196
OI CVCL_1540 ! NCI-H2198
SX Male
CA Transformed cell line
//
ID NCI-BL2347
AC CVCL_2656
SY BL2347
DR CLO; CLO_0007978
DR ATCC; CRL-5970
DR BioSample; SAMN03472627
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1550 ! NCI-H2347
SX Female
CA Transformed cell line
//
ID NCI-BL2882
AC CVCL_S844
SY BL2882
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5158 ! NCI-H2882
SX Female
CA Transformed cell line
//
ID NCI-BL2887
AC CVCL_S845
SY BL2887
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5159 ! NCI-H2887
SX Male
CA Transformed cell line
//
ID NCI-BL289
AC CVCL_E095
SY BL289
RX PubMed=8806092;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A554 ! NCI-H289
SX Female
CA Transformed cell line
//
ID NCI-EC1
AC CVCL_N841
DR Cosmic; 1622892
RX PubMed=21882256;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-EC2
AC CVCL_N842
DR Cosmic; 1622893
RX PubMed=21882256;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-EWS-011
AC CVCL_M143
SY EWS-011
RX PubMed=12441322;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-EWS-021
AC CVCL_M144
SY EWS-021
RX PubMed=12441322;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-EWS-94
AC CVCL_M145
SY NCI-EWS-94(JR); EWS-94; JR
RX PubMed=9865744;
RX PubMed=11504746;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-EWS-95
AC CVCL_M146
SY NCI-EWS-95(SB); EWS-95; SB
RX PubMed=9865744;
RX PubMed=11504746;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H1008
AC CVCL_A481
SY H1008; H-1008
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1011
AC CVCL_A482
SY NCI-H-1011; H1011; H-1011
RX PubMed=3478125;
RX PubMed=8806089;
RX PubMed=8806092;
DI NCIt; C3789; Olfactory neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1045
AC CVCL_A469
SY H1045; H-1045
DR Cosmic; 850433
DR Cosmic; 877368
DR Cosmic; 1032408
DR Cosmic; 1891908
DR GEO; GSM1682801
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20679594;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 13
ST D16S539: 10,13
ST D5S818: 11
ST D7S820: 9
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1048
AC CVCL_1453
SY H1048; H-1048
DR BTO; BTO:0005974
DR CLO; CLO_0007979
DR EFO; EFO_0002248
DR ATCC; CRL-5853
DR BioSample; SAMN03471878
DR BioSample; SAMN03472573
DR CCLE; NCIH1048_LUNG
DR ChEMBL-Cells; CHEMBL3308763
DR ChEMBL-Targets; CHEMBL1075512
DR Cosmic; 687995
DR Cosmic; 844566
DR Cosmic; 877369
DR Cosmic; 1152481
DR Cosmic; 1759253
DR Cosmic; 1891919
DR Cosmic; 2125223
DR Cosmic-CLP; 687995
DR GDSC; 687995
DR GEO; GSM169449
DR GEO; GSM827489
DR GEO; GSM887350
DR GEO; GSM888428
DR GEO; GSM1670160
DR IGRhCellID; NCIH1048
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 12
ST D18S51: 12,16
ST D21S11: 31.2,33.2
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 8,15
ST FGA: 18,22
ST Penta D: 10
ST Penta E: 7,8
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18,19 (ATCC)
ST vWA: 17,19 (Cosmic-CLP; PubMed=20679594; PubMed=25877200)
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1059
AC CVCL_A483
SY H1059; H-1059
DR ATCC; CRL-5854
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Discontinued: ATCC; CRL-5854; true.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1061
AC CVCL_A484
SY H1061; H-1061
DR Cosmic; 844567
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A470 ! NCI-H1062
SX Female
CA Cancer cell line
//
ID NCI-H1062
AC CVCL_A470
SY H1062; H-1062; HU-1062
DR Cosmic; 687996
DR Cosmic; 844568
DR Cosmic; 877370
DR Cosmic; 1152482
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A484 ! NCI-H1061
SX Female
CA Cancer cell line
//
ID NCI-H1086
AC CVCL_A471
SY H1086; H-1086
DR Cosmic; 980940
DR Cosmic; 1032409
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1092
AC CVCL_1454
SY H1092; H-1092
DR CLO; CLO_0007980
DR EFO; EFO_0002249
DR ATCC; CRL-5855
DR BioSample; SAMN03473006
DR CCLE; NCIH1092_LUNG
DR ChEMBL-Cells; CHEMBL3308311
DR ChEMBL-Targets; CHEMBL2366351
DR Cosmic; 687997
DR Cosmic; 850434
DR Cosmic; 877104
DR Cosmic; 877371
DR Cosmic; 980941
DR Cosmic; 1021872
DR Cosmic; 1032410
DR Cosmic; 1891909
DR Cosmic; 1995517
DR Cosmic-CLP; 687997
DR GDSC; 687997
DR GEO; GSM887351
DR GEO; GSM888429
DR GEO; GSM1670161
DR GEO; GSM1682802
DR IGRhCellID; NCIH1092
DR KCLB; 91092
RX PubMed=1563005;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,14
ST D16S539: 11,12
ST D18S51: 14
ST D21S11: 29,33.2
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 21,24
ST Penta D: 12,13
ST Penta E: 13
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1105
AC CVCL_1455
SY H1105; H-1105
DR CLO; CLO_0007981
DR ATCC; CRL-5856
DR BioSample; SAMN03473007
DR CCLE; NCIH1105_LUNG
DR Cosmic; 687998
DR Cosmic; 844569
DR Cosmic; 877217
DR Cosmic; 877372
DR Cosmic; 908468
DR Cosmic; 980942
DR Cosmic; 1032411
DR Cosmic; 1995518
DR Cosmic-CLP; 908468
DR GDSC; 908468
DR GEO; GSM887352
DR GEO; GSM888430
DR GEO; GSM1670162
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 13,15
ST D21S11: 29,31.2
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 9,10
ST D8S1179: 10,13
ST FGA: 21
ST Penta D: 12
ST Penta E: 11
ST TH01: 9
ST TPOX: 10,11
ST vWA: 14,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1112
AC CVCL_A485
SY H1112; H-1112
DR Cosmic; 720787
DR Cosmic; 760394
DR Cosmic; 2081382
DR Cosmic; 2302406
DR Cosmic; 2367272
RX PubMed=8806092;
RX PubMed=8943038;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H1155
AC CVCL_1456
SY H1155; H-1155; NCIH1155; NCI-1155
DR BTO; BTO:0005292
DR CLO; CLO_0007982
DR EFO; EFO_0002250
DR ATCC; CRL-5818
DR BCRJ; 0360
DR BioSample; SAMN03471357
DR CCLE; NCIH1155_LUNG
DR ChEMBL-Cells; CHEMBL3308312
DR ChEMBL-Targets; CHEMBL2366073
DR Cosmic; 722065
DR Cosmic; 724864
DR Cosmic; 801592
DR Cosmic; 844815
DR Cosmic; 852005
DR Cosmic; 876176
DR Cosmic; 877264
DR Cosmic; 877415
DR Cosmic; 908467
DR Cosmic; 918002
DR Cosmic; 934544
DR Cosmic; 961836
DR Cosmic; 980970
DR Cosmic; 1004692
DR Cosmic; 1032442
DR Cosmic; 1219080
DR Cosmic; 1239924
DR Cosmic; 1870263
DR Cosmic; 1995519
DR Cosmic; 2125224
DR Cosmic-CLP; 908467
DR GDSC; 908467
DR GEO; GSM62325
DR GEO; GSM206470
DR GEO; GSM253401
DR GEO; GSM784260
DR GEO; GSM794308
DR GEO; GSM827480
DR GEO; GSM887353
DR GEO; GSM888431
DR GEO; GSM1670163
DR IGRhCellID; NCIH1155
DR KCLB; 91155
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 91155; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 14
ST D16S539: 9
ST D18S51: 16
ST D21S11: 32.2
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 8
ST D8S1179: 14,16
ST FGA: 26
ST Penta D: 9
ST Penta E: 10
ST TH01: 6
ST TPOX: 8
ST vWA: 15
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1173
AC CVCL_1457
SY H1173; H-1173
DR ATCC; CRL-5857
DR Cosmic; 687999
DR Cosmic; 1998279
DR GEO; GSM536326
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Discontinued: ATCC; CRL-5857; true.
CC Derived from metastatic site: Soft tissue.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1184
AC CVCL_1458
SY H1184; H-1184; NCIH1184
DR CLO; CLO_0007983
DR ATCC; CRL-5858
DR BioSample; SAMN03472574
DR BioSample; SAMN03473568
DR CCLE; NCIH1184_LUNG
DR Cosmic; 688000
DR Cosmic; 852001
DR Cosmic; 877218
DR Cosmic; 980943
DR Cosmic; 1032412
DR Cosmic; 1518089
DR Cosmic; 1891910
DR Cosmic; 2125225
DR DSMZ; ACC-502
DR GDSC; 688000
DR GEO; GSM794309
DR GEO; GSM845539
DR GEO; GSM844616
DR GEO; GSM887354
DR GEO; GSM888432
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=20679594;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-70 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; DSMZ; PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10,12 (ATCC; DSMZ)
ST D7S820: 12 (PubMed=20679594)
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 16 (ATCC)
ST vWA: 16,17 (DSMZ; PubMed=20679594)
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2635 ! NCI-BL1184
SX Male
CA Cancer cell line
//
ID NCI-H1185
AC CVCL_A486
SY H1185; H-1185
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H123
AC CVCL_A487
SY H123; H-123
DR Cosmic; 1021851
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1238
AC CVCL_1459
SY H1238; H-1238
DR CLO; CLO_0007984
DR ATCC; CRL-5859
DR BioSample; SAMN03472575
DR Cosmic; 877219
DR Cosmic; 877373
DR Cosmic; 980944
DR Cosmic; 1032413
DR GEO; GSM794310
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,14
ST D16S539: 10
ST D5S818: 13
ST D7S820: 11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H125
AC CVCL_3968
SY H125; H-125; NCI-Hut 125; NCI-HUT-125; NCI-HUT 125; HUT-125; HUT 125; HUT125
DR BTO; BTO:0002822
DR BTO; BTO:0003010
DR EFO; EFO_0003116
DR ATCC; CRL-5801
DR BioSample; SAMN03471737
DR CCRID; 3111C0002000000022
DR ChEMBL-Cells; CHEMBL3307888
DR ChEMBL-Targets; CHEMBL614159
DR Cosmic; 844593
DR Cosmic; 877401
DR Cosmic; 931373
DR Cosmic; 1028943
DR Cosmic; 1032431
DR Cosmic; 1152496
DR GEO; GSM784259
DR GEO; GSM794271
DR KCLB; 90125
RX PubMed=8806092;
RX PubMed=9649128;
RX PubMed=11030152;
RX PubMed=11369051;
RX PubMed=20679594;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5801; true.
CC Discontinued: KCLB; 90125; probable.
ST Source(s): ATCC; PubMed=20679594
ST Amelogenin: X (ATCC)
ST Amelogenin: X,Y (PubMed=20679594)
ST CSF1PO: 7
ST D13S317: 11
ST D16S539: 5,12
ST D5S818: 10
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1264
AC CVCL_3970
SY H1264; H-1264
DR BTO; BTO:0003012
DR ATCC; CRL-5860
DR BioSample; SAMN03151857
DR BioSample; SAMN03472576
DR Cosmic; 724865
DR Cosmic; 844600
DR Cosmic; 877262
DR Cosmic; 877416
DR Cosmic; 903584
DR Cosmic; 930490
DR Cosmic; 1152508
DR KCLB; 91264
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=9649128;
RX PubMed=11030152;
RX PubMed=11369051;
WW http://www.atcc.org/support/faqs/05d55/Cross-contamination%20of%20ATCC%20CRL-5802%20and%20ATCC%20CRL-5860-931.aspx
WW http://www.atcc.org/support/faqs/78ebc/Contaminating%20Line%20for%20ATCC%20CRL5802%20vs%20ATCC%20CRL5860-932.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
CC Discontinued: ATCC; CRL-5860; true.
CC Discontinued: KCLB; 91264; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 6,12
ST vWA: 15
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0463 ! NCI-H157
SX Male
CA Cancer cell line
//
ID NCI-H128
AC CVCL_1460
SY NCI-H-128; H128; H-128; NCI-128
DR BTO; BTO:0003025
DR CLO; CLO_0007985
DR ATCC; CCL-258
DR ATCC; HTB-120
DR BioSample; SAMN03471389
DR ChEMBL-Cells; CHEMBL3307427
DR ChEMBL-Targets; CHEMBL614771
DR CLS; 300181/NA
DR Cosmic; 753597
DR Cosmic; 756013
DR Cosmic; 844547
DR Cosmic; 877199
DR Cosmic; 980928
DR Cosmic; 1021852
DR Cosmic; 1032394
DR Cosmic; 1219098
DR Cosmic; 1239936
DR Cosmic; 1518092
DR Cosmic; 1998281
DR Cosmic; 2125226
DR Cosmic; 2239096
DR Cosmic-CLP; 753597
DR GDSC; 753597
DR GEO; GSM380508
DR GEO; GSM536327
DR GEO; GSM794272
DR GEO; GSM1670164
DR KCLB; 30120
RX DOI=10.5795/jjscc.24.451;
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=6108156;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CCL-258; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 13
ST D5S818: 9
ST D7S820: 8,10
ST TH01: 6,9 (ATCC)
ST TH01: 6 (Cosmic-CLP)
ST TPOX: 8
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2636 ! NCI-BL128
SX Male
CA Cancer cell line
//
ID NCI-H1284
AC CVCL_1461
SY H1284; H-1284
DR ATCC; CRL-5861
DR BioSample; SAMN03472577
DR Cosmic; 753598
DR Cosmic; 844570
DR Cosmic; 877374
DR Cosmic; 980945
DR Cosmic; 1021873
DR Cosmic; 1032414
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20679594;
CC Discontinued: ATCC; CRL-5861; true.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 9,10,11
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1299
AC CVCL_0060
SY H1299; H-1299; NCIH1299
DR BTO; BTO:0002552
DR CLO; CLO_0007986
DR EFO; EFO_0003043
DR MCCL; MCC:0000352
DR ATCC; CRL-5803
DR BCRJ; 0185
DR BioSample; SAMN03471642
DR BioSample; SAMN03471739
DR CCLE; NCIH1299_LUNG
DR CCRID; 3111C0002000000050
DR CCRID; 3131C0001000700160
DR ChEMBL-Cells; CHEMBL3308501
DR ChEMBL-Targets; CHEMBL612255
DR Cosmic; 722069
DR Cosmic; 724831
DR Cosmic; 877265
DR Cosmic; 877418
DR Cosmic; 903585
DR Cosmic; 961838
DR Cosmic; 980971
DR Cosmic; 1004693
DR Cosmic; 1032443
DR Cosmic; 1047106
DR Cosmic; 1066159
DR Cosmic; 1146875
DR Cosmic; 1154606
DR Cosmic; 1175867
DR Cosmic; 1218870
DR Cosmic; 1239925
DR Cosmic; 1609524
DR Cosmic; 1870264
DR Cosmic; 1925845
DR Cosmic; 1995520
DR Cosmic; 2042873
DR Cosmic; 2125178
DR Cosmic-CLP; 724831
DR GDSC; 724831
DR GEO; GSM185871
DR GEO; GSM206471
DR GEO; GSM253382
DR GEO; GSM353229
DR GEO; GSM434266
DR GEO; GSM784253
DR GEO; GSM794311
DR GEO; GSM827467
DR GEO; GSM844617
DR GEO; GSM887355
DR GEO; GSM888433
DR GEO; GSM1374698
DR GEO; GSM1374699
DR GEO; GSM1670165
DR IGRhCellID; H1299GEO
DR KCLB; 25803
DR KCLB; 91299
DR TOKU-E; 2592
DR TOKU-E; 3620
DR Wikidata; Q5628772
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=24335698;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/H1299
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-15.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-173.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 30 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'HI299'.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=24335698; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 16
ST D21S11: 32.2
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 10,13
ST FGA: 20
ST Penta D: 13
ST Penta E: 11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,17,18 (ATCC)
ST vWA: 16,18 (Cosmic-CLP; PubMed=20679594; PubMed=24335698; PubMed=25877200)
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1304
AC CVCL_1462
SY H1304; H-1304
DR CLO; CLO_0007987
DR ATCC; CRL-5862
DR BioSample; SAMN03151858
DR BioSample; SAMN03472578
DR ChEMBL-Cells; CHEMBL3308554
DR ChEMBL-Targets; CHEMBL2366266
DR Cosmic; 753599
DR Cosmic; 877220
DR Cosmic; 877375
DR Cosmic; 1021874
DR Cosmic; 1032415
DR Cosmic-CLP; 753599
DR GDSC; 753599
DR GEO; GSM1670166
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=27397505;
WW http://www.atcc.org/support/faqs/d2b8d/NCIH1304%20ATCC%20CRL5862-1069.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: ATCC; CRL-5862; true.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 14
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1502 ! NCI-H1870
SX Female
CA Cancer cell line
//
ID NCI-H1315
AC CVCL_A488
SY H1315; H-1315
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1330
AC CVCL_A489
SY H1330; H-1330
RX PubMed=8806092;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1334
AC CVCL_3971
SY H1334; H-1334
DR BTO; BTO:0003011
DR EFO; EFO_0003117
DR ATCC; CRL-5863
DR Cosmic; 844596
DR Cosmic; 877419
DR Cosmic; 903586
DR Cosmic; 980972
DR Cosmic; 1032444
DR Cosmic; 1152509
DR Cosmic; 1891888
DR KCLB; 91334
RX PubMed=2386953;
RX PubMed=8806092;
RX PubMed=11030152;
CC Problematic cell line: Probably contaminated. The STR profile is identical to that of the NCI-H322 cell line. Originally thought to originate from a large cell lung carcinoma.
CC Discontinued: ATCC; CRL-5863; true.
ST Source(s): ATCC; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 17
ST D21S11: 28
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 12,15
ST FGA: 22
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1556 ! NCI-H322
SX Male
CA Cancer cell line
//
ID NCI-H1339
AC CVCL_A472
AS CVCL_2052
SY H1339; H-1339
DR ATCC; CRL-5979
DR BioSample; SAMN03473058
DR CCLE; NCIH1339_LUNG
DR Cosmic; 877376
DR Cosmic; 980946
DR Cosmic; 1032416
DR Cosmic; 1239942
DR Cosmic; 1513490
DR Cosmic; 1891911
DR Cosmic; 2125227
DR DSMZ; ACC-506
DR GEO; GSM887356
DR GEO; GSM888434
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5979; true.
CC Discontinued: DSMZ; ACC-506; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 13,15
ST D21S11: 32
ST D3S1358: 17,18
ST D5S818: 13
ST D7S820: 12
ST D8S1179: 14,16
ST FGA: 22,23
ST Penta D: 2.2
ST Penta E: 7
ST TH01: 7,9
ST TPOX: 6,12
ST vWA: 15
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2637 ! NCI-BL1339
SX Female
CA Cancer cell line
//
ID NCI-H134
AC CVCL_HA42
SY H134
RX PubMed=6108156;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1341
AC CVCL_1463
SY H1341; H-1341
DR CLO; CLO_0007988
DR ATCC; CRL-5864
DR BioSample; SAMN03472580
DR CCLE; NCIH1341_LUNG
DR Cosmic; 844571
DR Cosmic; 877377
DR Cosmic; 1152483
DR Cosmic-CLP; 1330964
DR GDSC; 1330964
DR GEO; GSM887357
DR GEO; GSM888435
DR GEO; GSM986178
DR GEO; GSM1670167
DR GEO; GSM1682803
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 11
ST D5S818: 13
ST D7S820: 9
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1355
AC CVCL_1464
SY H1355; H-1355; NCIH1355
DR BTO; BTO:0004823
DR CLO; CLO_0007989
DR EFO; EFO_0002251
DR ATCC; CRL-5865
DR BioSample; SAMN03471876
DR CCLE; NCIH1355_LUNG
DR ChEMBL-Cells; CHEMBL3308876
DR ChEMBL-Targets; CHEMBL2366227
DR Cosmic; 722056
DR Cosmic; 724866
DR Cosmic; 903587
DR Cosmic; 1146876
DR Cosmic; 1995521
DR Cosmic-CLP; 724866
DR GDSC; 724866
DR GEO; GSM253322
DR GEO; GSM434326
DR GEO; GSM482107
DR GEO; GSM794312
DR GEO; GSM844618
DR GEO; GSM887358
DR GEO; GSM888436
DR GEO; GSM1670168
DR IGRhCellID; NCIH1355
DR KCLB; 91355
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 91355; probable.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,13
ST D18S51: 11,17
ST D21S11: 31,32.2
ST D3S1358: 18
ST D5S818: 11,13
ST D7S820: 12
ST D8S1179: 14,16
ST FGA: 22,23
ST Penta D: 13,15
ST Penta E: 14
ST TH01: 9
ST TPOX: 9,12
ST vWA: 14,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1373
AC CVCL_1465
SY H1373; H-1373
DR CLO; CLO_0007990
DR EFO; EFO_0006657
DR ATCC; CRL-5866
DR BioSample; SAMN03470836
DR CCLE; NCIH1373_LUNG
DR Cosmic; 722040
DR Cosmic; 903588
DR Cosmic; 930488
DR Cosmic; 980973
DR Cosmic; 1032445
DR GEO; GSM794313
DR GEO; GSM887359
DR GEO; GSM888437
DR KCLB; 91373
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 91373; probable.
ST Source(s): ATCC; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 6
ST D16S539: 10
ST D18S51: 15
ST D21S11: 28,30.2
ST D3S1358: 17,18
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 13,16
ST FGA: 20,24
ST Penta D: 9,10
ST Penta E: 5
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1378
AC CVCL_A490
SY H1378; H-1378
RX PubMed=8806092;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1385
AC CVCL_1466
SY H1385; H-1385
DR CLO; CLO_0007991
DR ATCC; CRL-5867
DR BioSample; SAMN03472581
DR CCLE; NCIH1385_LUNG
DR Cosmic; 687793
DR Cosmic; 722041
DR Cosmic; 877420
DR Cosmic; 903589
DR Cosmic; 930489
DR Cosmic; 980974
DR Cosmic; 1032446
DR Cosmic; 1219081
DR Cosmic; 1891889
DR Cosmic; 2125228
DR GDSC; 1330965
DR GEO; GSM794314
DR GEO; GSM887360
DR GEO; GSM888438
DR KCLB; 91385
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 9,11
ST D3S1358: 14,18
ST D5S818: 13
ST D7S820: 8,10
ST FGA: 24
ST TH01: 7
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1387
AC CVCL_A491
SY H1387; H-1387
RX PubMed=8806092;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1395
AC CVCL_1467
SY H1395; H-1395; NCIH1395
DR CLO; CLO_0007992
DR EFO; EFO_0002252
DR ATCC; CRL-5868
DR BioSample; SAMN03471877
DR CCLE; NCIH1395_LUNG
DR CCRID; 3131C0001000700163
DR ChEMBL-Cells; CHEMBL3308313
DR ChEMBL-Targets; CHEMBL2366201
DR Cosmic; 684681
DR Cosmic; 877421
DR Cosmic; 903590
DR Cosmic; 917387
DR Cosmic; 961839
DR Cosmic; 980975
DR Cosmic; 1006535
DR Cosmic; 1032447
DR Cosmic; 1146877
DR Cosmic; 1154593
DR Cosmic; 1209731
DR Cosmic; 1219082
DR Cosmic; 1239884
DR Cosmic; 1518082
DR Cosmic; 1802318
DR Cosmic; 1891890
DR Cosmic; 1995522
DR Cosmic; 2125192
DR Cosmic-CLP; 684681
DR GDSC; 684681
DR GEO; GSM62324
DR GEO; GSM253353
DR GEO; GSM434277
DR GEO; GSM645857
DR GEO; GSM721892
DR GEO; GSM784222
DR GEO; GSM794315
DR GEO; GSM844619
DR GEO; GSM844620
DR GEO; GSM887361
DR GEO; GSM888439
DR GEO; GSM1670169
DR IGRhCellID; NCIH1395
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=8806092;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=14762065;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H1395.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,14
ST D16S539: 11,13
ST D18S51: 12,14
ST D19S433: 13,16
ST D21S11: 29
ST D2S1338: 17,24
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 12,14
ST FGA: 18,23
ST Penta D: 12
ST Penta E: 7
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2638 ! NCI-BL1395
SX Female
CA Cancer cell line
//
ID NCI-H1404
AC CVCL_1468
SY H1404; H-1404
DR CLO; CLO_0007993
DR ATCC; CRL-5819
DR BioSample; SAMN03471744
DR Cosmic; 877422
DR Cosmic; 903591
DR GDSC; 1330969
DR IGRhCellID; NCIH1404
DR KCLB; 91404
RX PubMed=2386953;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=11030152;
CC Discontinued: KCLB; 91404; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,14
ST D16S539: 12
ST D5S818: 12
ST D7S820: 11,14
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 19
DI NCIt; C5650; Papillary lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1412
AC CVCL_A492
SY H1412; H-1412
RX PubMed=8806092;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1417
AC CVCL_1469
SY H1417; H-1417
DR CLO; CLO_0007994
DR ATCC; CRL-5869
DR BCRJ; 0186
DR BioSample; SAMN03473062
DR ChEMBL-Cells; CHEMBL3308854
DR ChEMBL-Targets; CHEMBL2366149
DR Cosmic; 688001
DR Cosmic; 877221
DR Cosmic; 877378
DR Cosmic; 931447
DR Cosmic; 980947
DR Cosmic; 1032417
DR Cosmic; 2125170
DR Cosmic-CLP; 688001
DR GDSC; 688001
DR GEO; GSM169432
DR GEO; GSM827504
DR GEO; GSM1670170
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 12,13
ST D18S51: 17,18
ST D21S11: 28,29
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 12,14
ST FGA: 21,22
ST Penta D: 9,13
ST Penta E: 9,10
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1435
AC CVCL_1470
SY H1435; H-1435
DR BTO; BTO:0003004
DR CLO; CLO_0007995
DR EFO; EFO_0006658
DR ATCC; CRL-5870
DR BioSample; SAMN03471391
DR CCLE; NCIH1435_LUNG
DR Cosmic; 903592
DR Cosmic; 1028944
DR Cosmic-CLP; 1298347
DR GDSC; 1298347
DR GEO; GSM206472
DR GEO; GSM827361
DR GEO; GSM887362
DR GEO; GSM888440
DR GEO; GSM1670171
DR GEO; GSM1682804
DR KCLB; 91435
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 8,11
ST D16S539: 11
ST D18S51: 17
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 12,14
ST D8S1179: 12,13
ST FGA: 22 (KCLB)
ST FGA: 22,23 (PubMed=25877200)
ST Penta D: 11,12
ST Penta E: 5,12
ST TH01: 6,7
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H1436
AC CVCL_1471
SY H1436; H-1436
DR CLO; CLO_0007996
DR EFO; EFO_0002253
DR ATCC; CRL-5871
DR BioSample; SAMN03473008
DR CCLE; NCIH1436_LUNG
DR ChEMBL-Cells; CHEMBL3308893
DR ChEMBL-Targets; CHEMBL2366205
DR Cosmic; 688002
DR Cosmic; 844572
DR Cosmic; 908469
DR Cosmic; 2125229
DR Cosmic-CLP; 908469
DR GDSC; 908469
DR GEO; GSM887363
DR GEO; GSM888441
DR GEO; GSM1670172
DR GEO; GSM1682805
DR IGRhCellID; NCIH1436
DR KCLB; 91436
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 13
ST D18S51: 14,17
ST D21S11: 30.2,32.2
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 9,11
ST D8S1179: 8,13
ST FGA: 19,21
ST Penta D: 9,13
ST Penta E: 11
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1437
AC CVCL_1472
SY H1437; H-1437; NCIH1437
DR BTO; BTO:0003244
DR CLO; CLO_0007997
DR EFO; EFO_0002254
DR ATCC; CRL-5872
DR BioSample; SAMN03471451
DR CCLE; NCIH1437_LUNG
DR ChEMBL-Cells; CHEMBL3308764
DR ChEMBL-Targets; CHEMBL1075513
DR Cosmic; 687794
DR Cosmic; 877241
DR Cosmic; 877423
DR Cosmic; 903593
DR Cosmic; 917388
DR Cosmic; 980976
DR Cosmic; 1032448
DR Cosmic; 1146878
DR Cosmic; 1219084
DR Cosmic; 1239885
DR Cosmic; 1320186
DR Cosmic; 1518083
DR Cosmic; 1694666
DR Cosmic; 1889784
DR Cosmic; 1891891
DR Cosmic; 1995523
DR Cosmic; 2125230
DR Cosmic-CLP; 687794
DR GDSC; 687794
DR GEO; GSM253308
DR GEO; GSM434302
DR GEO; GSM513939
DR GEO; GSM514325
DR GEO; GSM784208
DR GEO; GSM794316
DR GEO; GSM827483
DR GEO; GSM887364
DR GEO; GSM888442
DR GEO; GSM1374700
DR GEO; GSM1374701
DR GEO; GSM1670173
DR IGRhCellID; NCIH1437
DR KCLB; 91437
RX PubMed=8806092;
RX PubMed=16157194;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H1437.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 44 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 19
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 11,14
ST D7S820: 8,11
ST D8S1179: 11,13
ST FGA: 22
ST Penta D: 10
ST Penta E: 5,11
ST TH01: 6
ST TPOX: 9,10
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2639 ! NCI-BL1437
SX Male
CA Cancer cell line
//
ID NCI-H1440
AC CVCL_A493
SY H1440; H-1440
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H1447
AC CVCL_A494
SY H1447; H-1447
RX PubMed=8806092;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1450
AC CVCL_A466
SY H1450; H-1450
DR Cosmic; 844573
DR Cosmic; 877222
DR Cosmic; 877379
DR Cosmic; 980948
DR Cosmic; 1021875
DR Cosmic; 1032418
DR Cosmic; 1152484
DR Cosmic; 1239943
DR Cosmic; 1518100
DR Cosmic; 2125231
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
CC Derived from metastatic site: Bone marrow.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 12
ST D5S818: 11
ST D7S820: 11
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2640 ! NCI-BL1450
OI CVCL_A495 ! NCI-H1451
SX Male
CA Cancer cell line
//
ID NCI-H1451
AC CVCL_A495
SY H1451; H-1451
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2640 ! NCI-BL1450
OI CVCL_A466 ! NCI-H1450
SX Male
CA Cancer cell line
//
ID NCI-H146
AC CVCL_1473
SY H146; H-146; NCIH146
DR BTO; BTO:0003024
DR CLO; CLO_0007998
DR EFO; EFO_0006659
DR ATCC; HTB-173
DR BCRC; 60280
DR BioSample; SAMN03473245
DR CCLE; NCIH146_LUNG
DR CLS; 300182/p740_NCI-H146
DR Cosmic; 688003
DR Cosmic; 755462
DR Cosmic; 850431
DR Cosmic; 877200
DR Cosmic; 910899
DR Cosmic; 980929
DR Cosmic; 1021853
DR Cosmic; 1032395
DR Cosmic; 1434965
DR Cosmic; 1995524
DR Cosmic; 1998282
DR Cosmic-CLP; 910899
DR GDSC; 910899
DR GEO; GSM169433
DR GEO; GSM380509
DR GEO; GSM536328
DR GEO; GSM784247
DR GEO; GSM794273
DR GEO; GSM845540
DR GEO; GSM844621
DR GEO; GSM887365
DR GEO; GSM888443
DR GEO; GSM986172
DR GEO; GSM1670174
DR IGRhCellID; NCIH146
DR KCLB; 30173
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=6108156;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 15,17
ST D21S11: 30
ST D3S1358: 11
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 12,14
ST FGA: 23
ST Penta D: 13
ST Penta E: 12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H1466
AC CVCL_A496
SY H1466; H-1466
DR Cosmic; 877242
DR Cosmic; 1891892
RX PubMed=8806092;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
- 公告/新闻
